Provided by Tiger Trade Technology Pte. Ltd.

LEPU BIO

3.950
-0.285-6.73%
Volume:16.73M
Turnover:67.18M
Market Cap:7.13B
PE:26.52
High:4.255
Open:4.290
Low:3.930
Close:4.235
52wk High:10.500
52wk Low:3.550
Shares:1.80B
HK Float Shares:1.80B
Volume Ratio:1.50
T/O Rate:0.93%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.149
ROE:24.24%
ROA:-0.07%
PB:4.32
PE(LYR):26.52
PS:6.16

Loading ...

Lepu Biopharma (SEHK:2157) Stock Grapples With Profit Quality Concerns

Simply Wall St.
·
Aug 21

Lepu Biopharma FY26 H1 Profit Falls 15.2% to RMB 24.8 Million; Revenue Rises 12.1% to RMB 522.4 Million

Reuters
·
Aug 19

LEPU BIO Sets 19 August 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend

Bulletin Express
·
Aug 07

Lepu Biopharma Sets Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 07

LEPU BIO Maintains 1.80 Billion Issued Shares and Confirms Public Float Compliance for July 2026

Bulletin Express
·
Aug 03

Hong Kong Stock Movers: LEPU BIO Surges Nearly 4% After Positive Topline Results from Global Phase III CMG901 Trial

Stock News
·
Jul 28

Lepu Biopharma Reports Positive Top-Line Results from Global Phase III Trial of Cmg901 (azd0901)

Reuters
·
Jul 28

Lepu Biopharma Says Phase III CLARITY-Gastric01 Trial Meets Overall Survival Endpoint for Cmg901 in Late-line Gastric Cancer

Reuters
·
Jul 28

LEPU BIOPHARMA Names Ren Fangyuan Employee Representative Supervisor After Zhao Lixuan Resignation

Bulletin Express
·
Jul 15

LEPU BIO Announces New Employee Representative Supervisor Appointment

Stock News
·
Jul 15

Lepu Biopharma Names Ren Fangyuan Employee Representative Supervisor, Replacing Zhao Lixuan

Reuters
·
Jul 15

LEPU BIO Shares Surge Again, Gaining Over 7% on Promising Drug Candidate

Stock News
·
Jul 15

Lepu Biopharma (SEHK:2157) Rebound Puts Its Valuation Back In Focus

Simply Wall St.
·
Jul 08

LEPU BIO Posts Static Share Capital in June 2026, Confirms Sufficient Public Float

Bulletin Express
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

LEPU BIO Shares Surge Over 13% in Morning Session as Analyst Highlights Potential of MRG006A in Liver Cancer Treatment

Stock News
·
Jun 29

LEPU BIO Shares Surge Over 6% in Afternoon Trading on Promising Liver Cancer Drug Data

Stock News
·
Jun 12

LEPU BIO-B Maintains 1.80 Billion Issued Shares in May 2026; Public Float Remains Compliant

Bulletin Express
·
Jun 01

Lepu Biopharma Updates Articles of Association; Registered Capital Set at RMB 1.80 Billion

Bulletin Express
·
May 19

LEPU Biopharma Shareholders Endorse All 2025 AGM Items, Confirm New Supervisor and Shanghai Registered Address

Bulletin Express
·
May 19